These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1783325)

  • 41. Expression of increased immunogenicity by thiol-releasing tumor variants.
    Lim JS; Eck HP; Gmünder H; Dröge W
    Cell Immunol; 1992 Apr; 140(2):345-56. PubMed ID: 1544166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reactivity of hypotaurine and cysteine sulfinic acid toward carbonate radical anion and nitrogen dioxide as explored by the peroxidase activity of Cu,Zn superoxide dismutase and by pulse radiolysis.
    Baseggio Conrado A; D'Angelantonio M; Torreggiani A; Pecci L; Fontana M
    Free Radic Res; 2014 Nov; 48(11):1300-10. PubMed ID: 25156684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in cell surface carbohydrates, and in laminin and fibronectin synthesis, between adherent and non-adherent Ehrlich ascites tumor cells.
    Song Z; Varani J; Goldstein IJ
    Int J Cancer; 1993 Dec; 55(6):1029-35. PubMed ID: 8253521
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early effects of cis-dichlorodiammine platinum (II) on tumor progression and programmed death of Ehrlich ascites carcinoma cells.
    Razin BV; Inzhevatkin EV; Nefedova VV; Egorova AB; Kazbanov VI; Nefedov VP
    Bull Exp Biol Med; 2001 Jun; 131(6):568-9. PubMed ID: 11586409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of cytotoxic antibiotic dactylarin with glycolytic thiol enzymes in Ehrlich ascites carcinoma cells.
    Sturdík E; Drobnica L
    J Antibiot (Tokyo); 1981 Jun; 34(6):708-12. PubMed ID: 6456251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The modulation of IL-2 dependent proliferation of CTLL-2 cells by 2-methyl-thiazolidine-2,4-dicarboxylic acid.
    Włodek L; Grabowska A; Marcinkiewicz J
    Immunopharmacology; 1995 Jun; 30(1):51-8. PubMed ID: 7591713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of levamisole on energy metabolism in Ehrlich ascites tumour cells in vitro.
    Gumińska M; Kedryna T; Marchut E
    Biochem Pharmacol; 1986 Dec; 35(24):4369-74. PubMed ID: 2947578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular thiols status and cell death in the effect of green tea polyphenols in Ehrlich ascites tumor cells.
    Kennedy DO; Matsumoto M; Kojima A; Matsui-Yuasa I
    Chem Biol Interact; 1999 Aug; 122(1):59-71. PubMed ID: 10475615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of tumour necrosis factor on growth of Ehrlich ascites tumour cells in vitro and in vivo.
    Fung KP; Leung SW; Ha DK; Ng SW; Choy YM; Lee CY
    Cancer Lett; 1985 Jul; 27(3):269-76. PubMed ID: 4016721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. S-methylthio-cysteine and cystamine are potent stimulators of thiol production and glutathione synthesis.
    Jókay I; Kelemenics K; Gyuris A; Minárovits J
    Life Sci; 1998; 62(2):PL27-33. PubMed ID: 9488118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of transforming growth factor-beta 1 antiproliferative effects on endothelial cells by cysteine, cystine, and N-acetylcysteine.
    Das SK; White AC; Fanburg BL
    J Clin Invest; 1992 Nov; 90(5):1649-56. PubMed ID: 1430195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human tumour necrosis factor-alpha inhibits glucose transport in cultured Ehrlich ascites tumour cells.
    Fung KP; Lam WP; Choy YM; Lee CY
    Life Sci; 1995; 57(1):PL1-6. PubMed ID: 7541099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro cell growth inhibition by metallocene dichlorides.
    Köpf-Maier P; Wagner W; Köpf H
    Cancer Chemother Pharmacol; 1981; 5(4):237-41. PubMed ID: 7261252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of hypotaurine and taurine in blood plasma of rats after the administration of L-cysteine.
    Yuasa S; Akagi R; Ubuka T
    Acta Med Okayama; 1990 Feb; 44(1):47-50. PubMed ID: 2330845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Catabolism of cysteine, cystine, cysteinesulfinate, and OTC by isolated perfused rat hindquarter.
    Ensunsa JL; Hirschberger LL; Stipanuk MH
    Am J Physiol; 1993 May; 264(5 Pt 1):E782-9. PubMed ID: 8098909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic application of cysteine-2:1-crotonal adduct for pharmacokinetic studies of tumor models in rats and mice.
    Tillian M; Wintersteiger R; Gübitz G
    Arzneimittelforschung; 1996 Jun; 46(6):640-2. PubMed ID: 8767358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reexamination of the interplay between dibasic amino acids and I-cystine/L-cysteine during tubular reabsorption.
    Völkl H; Silbernagl S
    Pflugers Arch; 1982 Nov; 395(3):196-200. PubMed ID: 7155793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Over-expression of the small heat-shock protein, hsp25, inhibits growth of Ehrlich ascites tumor cells.
    Knauf U; Bielka H; Gaestel M
    FEBS Lett; 1992 Sep; 309(3):297-302. PubMed ID: 1516700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of benfluron metabolites on glycolysis and level of thiol groups in P388 and Ehrlich ascites cells.
    Miko M; Krepelka J; Mĕlka M; Vajdová D
    Neoplasma; 1989; 36(3):305-15. PubMed ID: 2739809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioactivation of S-(2,2-dihalo-1,1-difluoroethyl)-L-cysteines and S-(trihalovinyl)-L-cysteines by cysteine S-conjugate beta-lyase: indications for formation of both thionoacylating species and thiiranes as reactive intermediates.
    Commandeur JN; King LJ; Koymans L; Vermeulen NP
    Chem Res Toxicol; 1996; 9(7):1092-102. PubMed ID: 8902263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.